13F Portfolios

Lynx1 Capital Management LP: PRECISION BIOSCIENCES INC (DTIL): Quarterly 13F Position History

As of Q1 2026, Lynx1 Capital Management LP reported 985,113 shares of PRECISION BIOSCIENCES INC (DTIL), worth $5.4M and representing 0.9% of its 13F equity book. Quarter-over-quarter share count change: 8,800 (-0.9%) . The position first appeared in Q4 2024 and has been disclosed across 6 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 6 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 985,113 8,800 -0.9% $5.4M 0.9% $5.5
Q4 2025 993,913 48,683 -4.7% $4.1M 0.8% $4.2
Q3 2025 1,042,596 +6,545 +0.6% $5.8M 1.2% $5.5
Q2 2025 1,036,051 +270,000 +35.2% $4.4M 1.3% $4.2
Q1 2025 766,051 0 $3.7M 1.3% $4.8
Q4 2024 766,051 $2.9M 1.1% $3.8

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Lynx1 Capital Management LP first disclose a DTIL position in 13F-HR filings?

Lynx1 Capital Management LP first reported PRECISION BIOSCIENCES INC (DTIL) on its 13F-HR filing for the period ending 2024-12-31 (Q4 2024). The position has appeared on 6 reported quarters within Pactolio's tracked window.

What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in DTIL?

Between Q4 2025 and Q1 2026, Lynx1 Capital Management LP reduced its DTIL position by 8,800 shares (-0.9%), leaving 985,113 shares at a market value of $5.4M.

Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in DTIL?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.